Elective mergery

15 June 2016 By Jeffrey Goldfarb

AmSurg and Envision are combining in a $10 bln stock deal with each owning roughly half. They’re keeping two headquarters and yet still expect $100 mln of synergies, including “meaningful” ones from new revenue. It’s a dubious proposition that seems mostly like empire-building.

This content is for Subscribers only

To access full Breakingviews.com content you must be a subscriber. Please use the following link to request a trial.

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)